Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 2,800 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
JCI Insight, 2021A system-view of Bordetella pertussis booster vaccine responses in adults primed with whole-cell versus acellular vaccine in infancy
da Silva Antunes R., Soldevila F., Pomaznoy M. et al.
Olink Target 96
Journal of Neurochemistry, 2021Cerebrospinal fluid and serum protein markers in autism: A co‐twin study
Smedler E., Kleppe J., Neufeld J. et al.
Scientific Reports, 2021A two-tiered targeted proteomics approach to identify pre-diagnostic biomarkers of colorectal cancer risk
Harlid S., Harbs J., Myte R. et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 2021Plasma Protein Profile of Carotid Artery Atherosclerosis and Atherosclerotic Outcomes
Lind L., Gigante B., Borné Y. et al.
European Journal of Heart Failure, 2021Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction
Woolley R., Ceelen D., Ouwerkerk W. et al.
Scientific Reports, 2021Disproportionate left atrial myopathy in heart failure with preserved ejection fraction among participants of the PROMIS-HFpEF study
Patel R., Lam C., Svedlund S. et al.
Nature Medicine, 2021A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity
Zhou S., Butler-Laporte G., Nakanishi T. et al.
Acta Neurologica Scandinavica, 2021Urokinase, CX3CL1, CCL2, TRAIL and IL‐18 induced by interferon‐β treatment
Zhukovsky C., Herman S., Wiberg A. et al.
Diabetes, 2021Differences in Biomarkers of Inflammation Between Novel Subgroups of Recent-Onset Diabetes
Herder C., Maalmi H., Strassburger K. et al.
Cancers, 2021A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOX
Stroes C., Schokker S., Molenaar R. et al.
Scientific Reports, 2021The relationship of indoxyl sulfate and p-cresyl sulfate with target cardiovascular proteins in hemodialysis patients
Wu P., Lin Y., Chiu Y. et al.
Biomarkers in Medicine, 2021Associations of Serially Measured Pcsk9, Ldlr and Mpo with Clinical Outcomes in Heart Failure
Bouwens E., Schuurman A., Akkerhuis K. et al.
Computer Methods and Programs in Biomedicine, 2021Artificial Intelligence-Based Prediction of Covid-19 Severity on the Results of Protein Profiling
Yaşar ?., Çolak C., Yoloğlu S.
Cardiovascular Ultrasound, 2021Pre- and postoperative left atrial and ventricular volumetric and deformation analyses in severe aortic regurgitation
Jenner J., Ilami A., Petrini J. et al.
Cancer Research, 2021Prospective Identification of Elevated Circulating CDCP1 in Patients Years before Onset of Lung Cancer
Dagnino S., Bodinier B., Guida F. et al.
Clinical Cancer Research, 2021A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer
Monjazeb A., Giobbie-Hurder A., Lako A. et al.
Nature Medicine, 2021Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma
Rozeman E., Hoefsmit E., Reijers I. et al.
Journal of Inherited Metabolic Disease, 2021Seizure phenotype in CLN3 disease and its relation to other neurologic outcome measures
Abdennadher M., Inati S., Soldatos A. et al.
Psychoneuroendocrinology, 2021Autoantibodies against the C-terminus of Lipopolysaccharide binding protein are elevated in young adults with psychiatric disease
Just D., Rasmusson A., Nilsson P. et al.
International Journal of Molecular Sciences, 2021Interplay between Humoral and CLA+ T Cell Response against Candida albicans in Psoriasis
de Jesús-Gil C., Sans-de San Nicolàs L., Ruiz-Romeu E. et al.
2846 publications
Items per page
2321-2340 of 2846 publications